Key facts
- It has raised $80K.
- Notable investors include Launch Tennessee, InvestTN, Start Capital, Boma Investments, Institute for Commercialization of Florida Technology — 7 tracked in total.
- New Day Diagnostics has filed 1 Form D with the SEC, most recently Aug 2023 ( sold).
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for New Day Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for New Day Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About New Day Diagnostics
Developer of non-invasive diagnostic tests designed to improve the detection of diseases. The company passionately serves and collaborates with healthcare professionals, the scientific community, and consumers alike by providing accurate, fast, and easy-to-use diagnostic tests that enable the early detection of a broad spectrum of diseases, helping health systems enhance the care they deliver with efficient and accurate tools.
- Sector
- Healthcare
- HQ
- Knoxville, TN, United States
- Founded
- 2005
- Employees
- 22
- Website
- newdaydiagnostics.com/
- Ownership
- Privately Held (backing)
New Day Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in New Day Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on New Day Diagnostics in its N-PORT filings yet. We sweep new filings monthly.